Risk of Dry Eye Post Different Surgeries for Blepharoptosis Repair

NCT02501187 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2018-04-13

No results posted yet for this study

Summary

Blepharoptosis, inferodisplacement of the upper eyelid, can be congenital or acquired. Acquired Blepharoptosis is usually aponeurotic, due to stretching or disinsertion of the levator aponeurosis. Treatment is surgical and can be performed by three common procedures - Levator advancement, Müller's muscle-conjunctival resection procedure and White line advancement. A number of reports inspected the possibility that Blepharoptosis repair procedures may cause deterioration in dry eye status. The investigators would like to assess whether there is a difference between the different procedures in their influence on dry eye status.

Conditions

  • Blepharoptosis

Interventions

PROCEDURE

Levator advancement

A transcutaneous procedure in which the Levator palpebrae aponeurosis is advanced and attached to the tarsus.

PROCEDURE

Müller's muscle-conjunctival resection procedure

A transconjunctival procedure in which part of the muller muscle and conjunctiva are resected.

PROCEDURE

White line advancement

A transconjunctival procedure in which the Levator palpebrae aponeurosis is advanced and attached to the tarsus.

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Maya Eiger, MD · Rabin Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-08
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02501187 on ClinicalTrials.gov